A once-monthly injection to control HIV proved as effective as daily pills in a second study by GlaxoSmithKline, paving the way for a new regimen that could be simpler for some patients to be filed with regulators.

https://ift.tt/2PsV9t0 support@endlesssupplies.biz (Endless Supplies .Biz) October 30, 2018 at 01:02PM
No comments:
Post a Comment